viewBraveheart Investment Group

Braveheart investee company P2F orders equipment to make face masks from 2021

A new production line has the capacity to produce up to five million standard or anti-viral face masks per month

Braveheart Investment Group -
P2F is testing anti-viral properties of the mask

Braveheart Investment Group (LON:BRH) noted that investee company Pharm2Farm (P2F) has ordered an automated face mask production line that should be commissioned by the end of 2020.

The production line has the capacity to produce up to five million standard or anti-viral face masks per month, said the investment company.

Braveheart pointed out that conventional surgical type masks are recommended to be used for a maximum of two hours but P2F’s version contains an additional defensive layer that uses nanotechnology engineered to kill viruses and bacteria.

This additional active layer added to the three in standard masks is expected to improve the wearer's safety for prolonged use, said Braveheart.

Testing of the new nanotechnology material and specifically the time taken to kill viruses including the coronavirus (COVID-19) is currently underway at the University of Nottingham with results due from the start of October.

Providing the tests are successful, commercial manufacturing of the new masks is expected in early 2021.

In the event the tests produce an unsatisfactory result, P2F can use the production line to make produce conventional surgical type masks profitably, said Braveheart.

Remote Monitored Systems PLC (LON:RMS), which agreed to acquire Braveheart's 51.7%  stake in P2F in August, simply noted the announcement in a statement today.

Quick facts: Braveheart Investment Group

Price: 50.98 GBX

Market: AIM
Market Cap: £17.7 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Braveheart Investment Group named herein, including the promotion by the Company of Braveheart Investment Group in any Content on the Site, the...


Braveheart Investment Group Pharm2Farm designs antiviral face mask to kill...

Braveheart Investment Group PLC (LON:BRH) investee company Pharm2Farm's (P2F) Gareth Cave talks to Proactive London about their new antiviral face mask that can kill coronavirus (COVID-19). Cave talks through the technology behind the mask, which is says is much stronger than the standard...

21 hours, 51 minutes ago

2 min read